Clinical Trial Update: Study to Assess the Tolerability and Efficacy of Anacetrapib (MK-0859) Co-Administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing tolerability and efficacy of anacetrapib co-administered with statin in participants with heterozygous familial hypercholesterolemia; tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia Familial
• Hyperlipoproteinemia Type Ii

Drugs mentioned

• Anacetrapib (anacetrapib)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hyperlipoproteinemia Type II, Hypercholesterolemia, Familial | Phase 3 | Status: COMPLETED | Results posted: 2019-08-28